Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cabaletta Bio stock

Learn how to easily invest in Cabaletta Bio stock.

Cabaletta Bio is a biotechnology business based in the US. Cabaletta Bio shares (CABA) are listed on the NASDAQ and all prices are listed in US Dollars. Cabaletta Bio employs 66 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Cabaletta Bio stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CABA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Cabaletta Bio stock price (NASDAQ: CABA)

Use our graph to track the performance of CABA stocks over time.

Cabaletta Bio shares at a glance

Information last updated 2023-05-26.
Latest market close$10.09
52-week range$0.59 - $13.44
50-day moving average $9.50
200-day moving average $6.17
Wall St. target price$14.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.59

Buy Cabaletta Bio stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Cabaletta Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cabaletta Bio price performance over time

Historical closes compared with the close of $10.09 from 2023-05-31

1 week (2023-05-25) 7.11%
1 month (2023-05-01) -11.49%
3 months (2023-03-01) 20.98%
6 months (2022-12-01) 115.60%
1 year (2022-06-01) 688.28%
2 years (2021-05-28) N/A
3 years (2020-06-01) 17.19%
5 years (2018-05-28) N/A

Cabaletta Bio financials

Gross profit TTM $0
Return on assets TTM -33.45%
Return on equity TTM -56.34%
Profit margin 0%
Book value $2.92
Market capitalisation $373.9 million

TTM: trailing 12 months

Cabaletta Bio share dividends

We're not expecting Cabaletta Bio to pay a dividend over the next 12 months.

Cabaletta Bio share price volatility

Over the last 12 months, Cabaletta Bio's shares have ranged in value from as little as $0.59 up to $13.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cabaletta Bio's is 2.5331. This would suggest that Cabaletta Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Cabaletta Bio overview

Cabaletta Bio, Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; CABA-201, a 4-1BB-containing CD19-CAR T investigational therapy, for the treatment of severe autoimmune diseases; PLA2R-CAART, a discovery stage product to treat patients with PLA2R-associated membranous nephropathy; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc.

Frequently asked questions

What percentage of Cabaletta Bio is owned by insiders or institutions?
Currently 10.981% of Cabaletta Bio shares are held by insiders and 76.358% by institutions.
How many people work for Cabaletta Bio?
Latest data suggests 66 work at Cabaletta Bio.
When does the fiscal year end for Cabaletta Bio?
Cabaletta Bio's fiscal year ends in December.
Where is Cabaletta Bio based?
Cabaletta Bio's address is: 2929 Arch Street, Philadelphia, PA, United States, 19104
What is Cabaletta Bio's ISIN number?
Cabaletta Bio's international securities identification number is: US12674W1099
What is Cabaletta Bio's CUSIP number?
Cabaletta Bio's Committee on Uniform Securities Identification Procedures number is: 12674W109

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site